Mark S. Blumenkranz Kala Pharmaceuticals, Inc. (KALA) insider trading activity

Mark S. Blumenkranz is of Kala Pharmaceuticals, Inc.. Currently has a direct ownership of 13,091 shares of KALA, which is worth approximately $92,815. The most recent transaction as insider was on Jun 11, 2024, when has been sold 1,400 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.1K

11.98% 3M change

11.98% 12M change

Total Value Held $92,815

Mark S. Blumenkranz Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 11 2024	BUY Grant, award, or other acquisition	-	1,400 Added 9.66%	13,091 Common Stock
Jun 22 2023	BUY Grant, award, or other acquisition	-	4,884 Added 29.47%	11,691 Common Stock
May 31 2023	BUY Grant, award, or other acquisition	-	1,640 Added 19.42%	6,807 Common Stock
Mar 10 2023	BUY Grant, award, or other acquisition	-	2,013 Added 28.04%	5,167 Common Stock
Feb 15 2023	SELL Other acquisition or disposition	-	3 Reduced 0.1%	3,154 Common Stock
Nov 15 2021	BUY Grant, award, or other acquisition	-	157,765 Added 50.0%	157,765 Common Stock

Also insider at

ISEE

IVERIC bio, Inc. Healthcare

Director

ONEM

1Life Healthcare Inc Healthcare

MSB